Picture of CellSource Co logo

4880 CellSource Co Income Statement

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapFalling Star

Annual income statement for CellSource Co, fiscal year end - October 31st, JPY millions except per share, conversion factor applied.

2019
October 31st
2020
October 31st
2021
October 31st
2022
October 31st
2023
October 31st
Period Length:12 M12 M12 M12 M12 M
Source:YuhoYuhoYuhoYuhoYuho
Standards:
JAS
JAS
JAS
JAS
JAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue1,6121,8552,9224,2744,511
Cost of Revenue
Gross Profit1,1541,2592,0743,0643,185
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses1,2851,4401,9302,7123,280
Operating Profit3274169921,5621,230
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes3034131,0061,5841,240
Provision for Income Taxes
Net Income After Taxes2002746511,018923
Net Income Before Extraordinary Items
Net Income2002746511,018923
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income2002746511,018923
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS15.314.333.953.347.6
Dividends per Share
Special Dividends per Share